“Apheris' innovative federated data platform allowed us to train robust predictive AI models with two of our partners while keeping all data private, onsite, and safe.”
Joining complementary data sets creates stronger machine learning capabilities. But valuable data containing intellectual property cannot be shared and must adhere to regulatory frameworks. Healthcare companies can use federated learning to work with decentralized data, allowing secure collaboration without sharing data.
In recent years, Deep Learning has gained considerable traction in many fields, but none more so than in the realm of drug discovery. Applications range from generating de novo hit-like molecules, predicting drug-disease associations and activity, toxicology estimation, to the analysis of medical images.
This case study shows the effectiveness of Apheris’ platform and services for data science on data that is not directly accessible and distributed. Federated learning decentralizes learning algorithms to access multiple data sets, maintaining privacy. Without pooling sensitive data, new insights can be uncovered securely.